CAS 1189734-21-1

Methotrimeprazine D6 (Racemic)

Description:

Methotrimeprazine D6 (Racemic) is a deuterated form of methotrimeprazine, a phenothiazine derivative primarily used for its antipsychotic and sedative properties. The "D6" designation indicates that the molecule contains six deuterium atoms, which are isotopes of hydrogen, replacing regular hydrogen atoms. This modification can enhance the stability and metabolic profile of the compound, making it useful in pharmacokinetic studies. Methotrimeprazine acts primarily as an antagonist at dopamine D2 receptors, contributing to its therapeutic effects in managing psychotic disorders and providing sedation. Additionally, it exhibits antihistaminic and anticholinergic properties, which can lead to side effects such as sedation, dry mouth, and potential extrapyramidal symptoms. The racemic nature of the compound indicates that it exists as a mixture of two enantiomers, which may have different pharmacological effects. Overall, Methotrimeprazine D6 (Racemic) serves as a valuable tool in both clinical and research settings, particularly in understanding the pharmacodynamics and pharmacokinetics of antipsychotic medications.

Formula: C₁₉H₂₅ClN₂OS

Synonyms:

• [2H6]- (±)-Methotrimeprazine Hydrochloride
• [2H6]-Methotrimeprazine (Racemic)
• Levomepromazine hydrochloride salt
• Methotrimeprazine D6 (Racemic)
• [2H6]-Levomepromazine hydrochloride

rac Methotrimeprazine-d6 Hydrochloride

Controlled Product

CAS: 1189734-21-1

Formula: C₁₉H₁₉D₆ClN₂OS

Color and Shape: Neat

Molecular weight: 370.97

Ref: TR-M260787